{"slideshow_credits": null, "snippet": "A report says that even as prescription costs have plummeted, a small slice of the population with serious illnesses is being asked to shoulder more of the cost of expensive treatments.", "abstract": "Report by IMS Institute for Healthcare Informatics, division of IMS Health, says that even as prescription drug costs have plummeted, small slice of population with serious illnesses is being asked to shoulder more of cost of expensive treatments; findings echo conclusions of other reports that predict spending on so-called specialty drugs will continue to rise.", "section_name": "Business Day", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Katie", "role": "reported", "lastname": "THOMAS", "rank": 1, "organization": ""}], "original": "By KATIE THOMAS", "contributor": ""}, "web_url": "http://www.nytimes.com/2014/04/15/business/prices-soaring-for-specialty-drugs-researchers-find.html", "lead_paragraph": "A report says that even as prescription costs have plummeted, a small slice of the population with serious illnesses is being asked to shoulder more of the cost of expensive treatments.", "headline": {"main": "Prices Soaring for Specialty Drugs, Researchers Find", "print_headline": "Prices Soaring for Specialty Drugs, Researchers Find"}, "_id": "534cb15b38f0d83d1cbe21ce", "word_count": "851", "multimedia": [], "pub_date": "2014-04-15T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Generic Brands and Products", "name": "subject", "is_major": "N", "rank": "4"}, {"value": "Health Insurance and Managed Care", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "IMS Institute for Healthcare Informatics", "name": "organizations", "is_major": "N", "rank": "3"}], "blog": [], "subsection_name": null, "type_of_material": "News"}